Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 491.89 USD -0.55% Market Closed
Market Cap: 127B USD
Have any thoughts about
Vertex Pharmaceuticals Inc?
Write Note

Vertex Pharmaceuticals Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vertex Pharmaceuticals Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
ALNY
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$595.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$2B
CAGR 3-Years
7%
CAGR 5-Years
-9%
CAGR 10-Years
-13%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$948m
CAGR 3-Years
26%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.4B
CAGR 3-Years
-34%
CAGR 5-Years
-29%
CAGR 10-Years
-15%
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Interest Income Expense
-$138.5m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$990m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vertex Pharmaceuticals Inc's Interest Income Expense?
Interest Income Expense
595.2m USD

Based on the financial report for Sep 30, 2024, Vertex Pharmaceuticals Inc's Interest Income Expense amounts to 595.2m USD.

What is Vertex Pharmaceuticals Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
24%

Over the last year, the Interest Income Expense growth was 24%.

Back to Top